Release
📈 Stocks
SpyGlass Pharma Acquires AVS for $13 Million to Scale IOL Manufacturing
(3 hours ago)
SpyGlass Pharma strengthens its supply chain by acquiring AVS from Santen Pharmaceutical for $13 million, securing essential manufacturing capacity for its Phase…